Company Profile
What's New
Product Information
Applications Info
Tech Reference List
Information Request
Contact Us
Careers
Email Newsletter
Frequently Asked Questions
In Vitro Basics
In Vitro Toxicology Testing (Non-Animal Safety Testing)
Nanoparticle Research Using MatTek Human Tissue Constructs
Site Map
Search




MatTek Corporation
200 Homer Avenue
Ashland, MA  01721
508-881-6771
FAX:  508-879-1532
E-mail Us

Reproducibility Guaranteed!
Front page
Search

Category: Technical References, EpiAirway

553. THE EFFICACY OF ECHINACEA IN A 3-D TISSUE MODEL OF HUMAN AIRWAY EPITHELIUM.


Sharma1, M., Schoop2, R., and Hudson1, J.B. 1Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada, 1A.Vogel Bioforce AG, Roggwil, Switzerland. Phytother. Res., DOI: 10.1002/ptr.3051, 2009.

Summary:
This study by researchers at the University of British Columbia and A. Vogel Bioforce AG demonstrated that MatTek’s EpiAirway in vitro 3-D human tracheal/bronchial tissue equivalent can be infected with rhinovirus type 1A (RV1A) and then used to evaluate the antirhinovirus efficacy of Echinacea purpurea.

Researchers evaluated the antirhinovirus efficacy of a standardized preparation of Echinacea purpurea (EchinaforceĀ®) in a 3-dimensional organotypic model of normal human airway epithelium (EpiAirway tissue).

Individual replicate tissue samples, maintained as inserts in culture for 3 days or 3 weeks, were infected with rhinovirus type 1A (RV1A), Echinacea alone, a combination of the two, or medium only. None of the treatments affected the histological appearance or integrity of the tissues, all of which maintained a high level of cell viability and preservation of cilia.

RV infection resulted in increased mucopolysaccharide inclusions in the goblet cells, but this feature was reversed by Echinacea treatment. This result was confirmed by measurements of mucin secretion, which was stimulated by RV but reversed by Echinacea, suggesting that mucus production during colds could be ameliorated by Echinacea.

The researchers did not find evidence of virus replication, although the RV-infected tissues secreted substantial amounts of the pro-inflammatory cytokines IL-6 and IL-8 (CXCL8), and this response was reversed by Echinacea treatment.

These results confirmed previous findings derived from studies of bronchial and lung epithelial cell lines, namely, that RV infection results in a substantial inflammatory response in the absence of virus replication.

====================

Request an Electronic Copy (PDF format) of this Technical Paper

====================

EpiAirway Data Sheet

EpiAirway Specifications

EpiAirway Technical References


Applications: Airway research, Drug delivery - airway, Flu virus research, Infectious disease research, Respiratory disease research

Keywords: AIR-100, Antirhinovirus efficacy, Cilia, EpiAirway, Goblet cells, Histology, IL-6, IL-8, MTT assay, MUC 5AC secretion, Mucin production, Mucin secretion, Mucopolysaccharide inclusions, PAS staining, Rhinoviruses, TNF-alpha, Tissue thickness

Materials Tested: Echinacea purpurea, Echinaforce, Rhinovirus type 1A



Top